Corporate$ARCT4:07 PM ET

Arcturus Therapeutics to acquire myNEO, an AI discovery company, to boost mRNA design and target identification

By BORSA NewsroomPublished Sep 23, 2026, 4:07 PM EDTUpdated Sep 25, 2026, 11:52 AM EDT

Arcturus Therapeutics (ARCT) announced it will acquire myNEO, an AI-driven discovery company, to enhance its mRNA design quality, accelerate innovation, and improve target identification capabilities. No further details were provided.

Sentimentbullish 70

Bullish · 70 of 100

Impact40

low · stays off the top drivers

Confidence80%

high confidence · single wire

Eventdeveloping

v1 · alerts feed only

WHAT WE KNOW

Arcturus Therapeutics to acquire myNEO.